In a groundbreaking study that sheds light on the elusive triggers of cataplexy, researchers have uncovered a pivotal role for the neuropeptide oxytocin in promoting muscle weakness episodes linked to strong positive emotions. Cataplexy, a hallmark symptom of narcolepsy, manifests as sudden muscle atonia that predominantly occurs during social interactions, and this new research positions oxytocin as a critical molecular mediator in this process.
Using a sophisticated mouse model of narcolepsy, the research team observed that social reunification—a highly positive social stimulus—precipitated episodes of cataplexy. Intriguingly, administration of an oxytocin antagonist was able to effectively block these socially induced cataplexy events, strongly implicating oxytocin signaling in the amygdala as a driving force behind the phenomenon.
High-resolution neurochemical monitoring revealed an increase in oxytocin tone just before the onset of cataplexy triggered by social cues. This was accompanied by heightened activity in oxytocin receptor-expressing neurons within the central amygdala, an emotional brain region known for its role in processing social behaviors and affective states. These findings suggest that oxytocin acts centrally to prime neural circuits that facilitate the transition into cataplexy.
Delving deeper, the study employed advanced chemogenetic and optogenetic methods to manipulate oxytocin-responsive neuronal populations directly. Activation of these central amygdala neurons resulted in the inhibition of specific brainstem neurons responsible for suppressing muscle atonia. In essence, the oxytocin-responsive amygdala neurons were shown to disinhibit the muscle atonia circuits, thereby triggering cataplexy.
What makes this discovery even more compelling is the identification that rewarding stimuli beyond social interaction can engage the same oxytocin–amygdala pathway. Chocolate, a potent and universally rewarding food stimulus known to evoke strong positive emotions, was found to induce cataplexy episodes in narcoleptic mice through activation of this same neural circuit.
This research not only clarifies the neural underpinnings of emotionally triggered cataplexy but also highlights the central amygdala as a potential target for therapeutic intervention. By modulating oxytocin signaling or selectively targeting oxytocin-responsive neurons in the amygdala, future treatments may be designed to suppress cataplexy without broad suppression of emotion or social engagement.
The implications extend beyond narcolepsy alone, offering fresh insights into how socio-affective brain circuits interface with motor control systems to affect muscle tone. This may inspire new lines of inquiry into the wider neurobiology of emotion-driven motor phenomena.
Overall, these findings expertly illustrate the complex interplay between neuropeptides, emotional processing centers, and motor inhibition pathways, opening promising avenues for managing one of narcolepsy’s most disruptive symptoms through targeted neurochemical modulation.
Subject of Research:
Article Title:
Article References: Mahoney, C.E., De Luca, R., Joyal, A.A. et al. Oxytocin promotes socially triggered cataplexy. Nat Neurosci (2026). https://doi.org/10.1038/s41593-026-02352-7
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41593-026-02352-7
Keywords: Narcolepsy, Cataplexy, Oxytocin, Central Amygdala, Muscle Atonia, Social Interaction, Reward, Chemogenetics, Optogenetics
